Meningitis News and Research

Latest Meningitis News and Research

Bacterial study confirms TLR2 signaling vital for activating human airway epithelial cells

Researchers from the Boston University School of Medicine (BUSM) have demonstrated that commensal species of the genus Neisseriae are low inducers of human airway epithelial cell responses as compared to the pathogenic species.

24 Nov 2010

Meningitis immunization program to launch in 3 African countries next month

At a press conference in London, health officials said that the anticipated roll-out of the MenAfriVac for meningitis in three African countries will start on Dec. 6, the BBC reports.

24 Nov 2010

Children's Surgical Centre offers no-cost surgery for children with frontoethmoidal meningoencephalocele

Frontoethmoidal meningoencephalocele is a type of facial malformation that is rarely seen in developed countries, but is quite common in many Southeast Asian countries, occurring in 1 of every 5,000 live births.

20 Nov 2010

Statins activate bacterial-killing properties of white blood cells

Widely prescribed for their cholesterol-lowering properties, recent clinical research indicates that statins can produce a second, significant health benefit: lowering the risk of severe bacterial infections such as pneumonia and sepsis.

18 Nov 2010

Sinovac third quarter sales decrease 7% to $9.6 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2010.

15 Nov 2010

Discovery on immune system paves way to new vaccine against pneumococcal disease

A new breakthrough in the fight against pneumonia, meningitis and septicaemia has been announced today by scientists in Leicester and Dublin. The discovery will lead to a dramatic shift in our understanding of how the body's immune system responds to infection caused by Streptococcus pneumoniae and pave the way for more effective vaccines.

12 Nov 2010

Nature News examines meningitis vaccine program to roll out in Africa

Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa's meningitis belt. Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides, the news service writes, noting the effort is the culmination of ten years' work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose.

12 Nov 2010

GBS meningitis in infants still very serious

Although now less frequent because of preventive antibiotics, meningitis caused by group B streptococcal (GBS) bacteria is still a serious illness causing a high rate of death and severe complications in infants, reports a study in the November issue of The Pediatric Infectious Disease Journal.

9 Nov 2010

Experts develop tools to educate people about health risks associated with global travel

More than 30 million people in the United States travel to resource-limited areas of the world each year. This global mobility may contribute to the spread of infectious diseases such as influenza, measles, and meningitis and may also put individual travelers at risk for malaria, typhoid, dengue fever and hepatitis.

4 Nov 2010

Scientists develop new method to analyze early detection of virus

The virus, called enterovirus 71, is closely related to poliovirus, and was first detected in California in the 1960s. Since then the virus has spread across Asia, affecting mostly children and some adults. Serious cases of the disease can include neurological disorders such as meningitis, paralysis and encephalitis.

29 Oct 2010

Racial disparities among children with frequent ear infections can influence access to health care resources

Ear infections are one of the most common health problems for children, with most kids experiencing at least one by their third birthday. Annual costs in the United States alone are in the billions of dollars.

26 Oct 2010

Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) as one of the five manufacturers to supply seasonal influenza vaccine to the citizens of Beijing.

25 Oct 2010

Sinovac Biotech receives Drug Registration Certificate for seasonal influenza vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary company in Hong Kong, has received the Certificate of Drug/Product Registration from the Hong Kong Department of Health for its seasonal influenza vaccine Anflu.

25 Oct 2010

Three West African countries set to roll out new meningitis vaccine

A new vaccine for meningitis, MenAfriVac, offers hope of an escape from one of the world's deadliest, most disabling and infectious diseases, the BBC writes. The vaccine was developed by non-governmental organization PATH in partnership with the WHO and created specifically for Africa.

18 Oct 2010

Scientists to monitor effectiveness of Streptococcus vaccine

Respiratory infections and diarrhoeal diseases kill approximately four million children each year, with most deaths occurring in developing countries. New vaccines for Streptococcus pneumoniae, a bacterium that causes pneumonia, and rotavirus, the most common cause of severe diarrhoea, have proved successful in preventing the development of the diseases in clinical trials, but have yet to be used routinely in many parts of Africa.

15 Oct 2010

FDA approves Gamunex-C for primary immunodeficiency treatment

Talecris Biotherapeutics announced today that the U.S. Food and Drug Administration (FDA) approved Gamunex-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the treatment of primary immunodeficiency (PI).

15 Oct 2010

Phase I study of Shigella dysenteriae bioconjugate vaccine meets primary, secondary endpoints

GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.

8 Oct 2010

Spanish mothers more concerned about the safety of childhood vaccines

Researchers from the University of Alicante (UA) taking part in the European VACSATC project have studied mothers' and fathers' opinions on vaccinating their children in five countries. The results of the survey show that Spanish mothers are more resistant than those in other countries to the idea of paying for vaccines, while 20.9% expressed some concern about the safety of vaccines.

8 Oct 2010

Rochester General Hospital Research Institute awarded $7M for Prevnar 13 study of ear infections in children

The Rochester General Hospital Research Institute has been awarded a $7.1 million grant to study the effectiveness of a new vaccine on the bacteria that cause ear infections in children. Michael E. Pichichero MD, Director of the Research Institute, has been named Principal Investigator of the five year study which will follow children who receive the Prevnar 13 vaccine. The vaccine is manufactured by Pfizer Vaccine Research of Collegeville, Pennsylvania which is funding the grant.

6 Oct 2010

Data shows Take Care Clinics’ quality of care exceeds national benchmarks

Take Care Health Systems, a wholly-owned subsidiary of Walgreens and the nation's largest and most comprehensive manager of convenient care clinics and worksite health and wellness centers, today announced that an analysis of de-identified data collected through the company's electronic medical record (EMR) system by the Jefferson School of Population Health showed that the quality of care delivered in Take Care Clinics for treatment of pharyngitis (inflammation of the throat) and upper respiratory infections (URI) meets or exceeds the quality of the care delivered in other settings.

5 Oct 2010

Meningitis News and Research

Latest Meningitis News and Research

Bacterial study confirms TLR2 signaling vital for activating human airway epithelial cells

Meningitis immunization program to launch in 3 African countries next month

Children's Surgical Centre offers no-cost surgery for children with frontoethmoidal meningoencephalocele

Statins activate bacterial-killing properties of white blood cells

Sinovac third quarter sales decrease 7% to $9.6 million

Discovery on immune system paves way to new vaccine against pneumococcal disease

Nature News examines meningitis vaccine program to roll out in Africa

GBS meningitis in infants still very serious

Experts develop tools to educate people about health risks associated with global travel

Scientists develop new method to analyze early detection of virus

Racial disparities among children with frequent ear infections can influence access to health care resources

Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine

Sinovac Biotech receives Drug Registration Certificate for seasonal influenza vaccine

Three West African countries set to roll out new meningitis vaccine

Scientists to monitor effectiveness of Streptococcus vaccine

FDA approves Gamunex-C for primary immunodeficiency treatment

Phase I study of Shigella dysenteriae bioconjugate vaccine meets primary, secondary endpoints

Spanish mothers more concerned about the safety of childhood vaccines

Rochester General Hospital Research Institute awarded $7M for Prevnar 13 study of ear infections in children

Data shows Take Care Clinics’ quality of care exceeds national benchmarks

Forensics and toxicology - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Meningitis News and Research

Latest Meningitis News and Research

Forensics and toxicology - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in